Related Experiment Video
Updated: Jun 26, 2026
Improved Methodology for Studying Postnatal Osteogenesis via Intramembranous Ossification in a Murine Bone Marrow Injury Model
Published on: February 7, 2025
Subtype-specific bone mineralization defects and early treatment amelioration in murine models of autosomal recessive
Marco Ventura1, Victor Alcolea-Rodriguez2, Chiara Agrimi2
1CNR-Institute for Photonics and Nanotechnologies (CNR-IFN), Milan, Italy.
Abstract:
Autosomal recessive osteopetrosis is a rare genetic disorder caused by impaired osteoclast function, leading to excessive bone mass, defective remodeling, and fragility fractures. While bone density alterations are well recognized, compositional parameters remain poorly characterized. Here, we applied Raman spectroscopy to characterize bone defects in two murine models, the RANKL-deficient Rankl-/- (mild form) and the TCIRG1-deficient oc/oc (severe form), compared with healthy controls. Raman analysis revealed a gradient in mineral-to-matrix ratio, progressively showing lower values from healthy to Rankl-/- and to oc/oc (skull: 2.93 ± 0.02 vs. 2.19 ± 0.31 vs. 1.72 ± 0.15, p < 0.05; long bone: 3.59 ± 0.56 vs. 2.60 ± 0.53 vs. 1.86 ± 0.17, p < 0.05 for all pairs except Rankl-/- vs oc/oc). Crystallinity showed overall lower values in osteopetrotic bones compared to WT, with partially overlapping distributions between Rankl-/- and oc/oc mice (skull: 0.050 ± 0.001 vs. 0.046 ± 0.001 vs. 0.048 ± 0.001; long bone: 0.050 ± 0.001 vs. 0.047 ± 0.001 vs. 0.048 ± 0.001 for WT, Rankl-/- and oc/oc, respectively). Multivariate analysis achieved 95% classification accuracy under exploratory animal-level cross-validation. In oc/oc mice treated with bone marrow transplantation, Raman analysis detected a significantly higher mineral-to-matrix ratio at day 18 compared to untreated oc/oc mice (2.668 ± 0.124 vs. 2.207 ± 0.311; p = 0.040, respectively). These findings identify genotype-specific compositional alterations in ARO models and provide proof-of-concept that Raman spectroscopy can characterize mineralization defects in intact bones ex vivo, suggesting that further development of non-invasive or minimally invasive Raman-based approaches may enable future studies of ARO progression and therapeutic response in clinically relevant settings.
Insights
Autosomal recessive osteopetrosis (ARO) involves impaired osteoclast function, leading to bone defects. Raman spectroscopy revealed genotype-specific bone composition changes in ARO mouse models, showing promise for diagnosing ARO and monitoring treatment.
Area of Science:
- Biochemistry
- Genetics
- Biophysics
Background:
- Autosomal recessive osteopetrosis (ARO) is a rare genetic disorder characterized by impaired osteoclast function, resulting in excessive bone mass and fragility fractures.
- While bone density changes are known, the specific compositional alterations in ARO remain poorly understood.
Purpose of the Study:
- To utilize Raman spectroscopy for characterizing bone compositional defects in murine models of ARO.
- To compare bone composition between RANKL-deficient (Rankl-/-) and TCIRG1-deficient (oc/oc) ARO models and healthy controls.
- To assess the potential of Raman spectroscopy in evaluating therapeutic interventions for ARO.
Main Methods:
- Raman spectroscopy was applied to analyze bone samples from Rankl-/-, oc/oc, and wild-type (WT) mice.
- Mineral-to-matrix ratio and crystallinity were quantified using Raman spectral analysis.
- Multivariate analysis was employed for classification accuracy.
- Bone marrow transplantation was performed in oc/oc mice, followed by Raman analysis to evaluate treatment effects.
Main Results:
- Raman spectroscopy revealed a progressive decrease in the mineral-to-matrix ratio from WT to Rankl-/- to oc/oc mice in both skull and long bones.
- Bone crystallinity was generally lower in osteopetrotic bones compared to WT, with overlapping distributions between Rankl-/- and oc/oc models.
- Multivariate analysis achieved 95% classification accuracy for distinguishing between ARO models and controls.
- In oc/oc mice treated with bone marrow transplantation, Raman analysis showed a significantly higher mineral-to-matrix ratio compared to untreated controls.
Conclusions:
- Raman spectroscopy can identify genotype-specific bone compositional alterations in ARO mouse models.
- This technique provides a proof-of-concept for characterizing mineralization defects in intact bones ex vivo.
- Further development of Raman-based approaches may facilitate non-invasive assessment of ARO progression and therapeutic responses in clinical settings.
